Author:
Cuquerella-Gilabert Marina,Reig-López Javier,Serna Jenifer,Rueda Ferreiro Almudena,Merino-Sanjuan Matilde,Mangas-Sanjuan Victor,Sánchez-Herrero Sergio
Reference55 articles.
1. Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making;R Madabushi;Pharm Res. Agosto de,2022
2. The FDA critical path initiative and its influence on new drug development;J Woodcock;Annu Rev Med,2008
3. Commentary on the MID3 Good Practices Paper;E Manolis;CPT Pharmacometrics Syst Pharmacol. Julio de,2017
4. Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development;F Khalil;J Biomed Biotechnol,2011